Results 151 to 160 of about 6,409,377 (315)

[Epidemiological characteristics of Angola].

Zhurnal mikrobiologii, epidemiologii i immunobiologii, 1985
The epidemiological analysis of infectious morbidity for recent years has been made and the main nosological forms existing in Angola (malaria, tuberculosis, lepra, African trypanosomiasis, plague, intestinal diseases, etc.) have been briefly characterized on the basis of primary medical reports and the data provided by the literature and experimental ...
openaire   +1 more source

Epidemiological, clinical and laboratory characteristics among the household contacts of leprosy patients.

, 2018
Epidemiological, clinical and laboratory characteristics among the household contacts of leprosy patients.
Raquel Campos Pereira (4621933), Luiz Ricardo Goulart (569752), Matheus Rocha Mendonça (4621936), Isabela Maria Bernardes Goulart (4621930), Elaine Fávaro Pípi Sabino (4621924), Diogo Fernandes dos Santos (4621939), Douglas Eulálio Antunes (4621927)   +6 more
core   +1 more source

Autoimmune Comorbidities as Modifiers of Phenotypic Heterogeneity in Facioscapulohumeral Dystrophy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral dystrophy type 1 (FSHD1) shows clinical heterogeneity that is only partly explained by D4Z4 repeat unit (RU) size. Although immune and inflammatory mechanisms may contribute to disease variability, the prevalence and clinical impact of autoimmune diseases in FSHD remain unclear.
Jonathan Pini, Giulia Tammam, Andra Ezaru, Manuela Gambella, Benoît Sanson, Luisa Villa, Michele Cavalli, Mihai‐Bogdan Ioncea, Angela Puma, Sabrina Sacconi   +9 more
wiley   +1 more source

Epidemiology of respiratory infectious diseases after the relaxation of COVID-19 policies: a retrospective study in Xiamen, China

Frontiers in Public Health
ObjectiveThis study aimed to analyze the epidemiological patterns of respiratory infectious diseases in Xiamen, Fujian Province, over the year following the relaxation of China’s COVID-19 control measures.MethodsWe conducted a comprehensive statistical ...
Linlin Qu, Xiaojun Jing, Ruopei Wang, Kai Zhang, Meiying Su, Lanlan Lian, Chunhua Yang, Houzhao Wang   +7 more
doaj   +1 more source

Clinical and epidemiological characteristics of patients with autochtonous strongyloidiasis in Spain.

, 2019
Clinical and epidemiological characteristics of patients with autochtonous strongyloidiasis in Spain.
Pau Bosch-Nicolau (6448832), Adrián Sánchez-Montalvá (2157286), Fernando Salvador (814802), Maria Barroso (6448829), Israel Molina (814809)   +4 more
core   +1 more source

Temporal Divergence of True and False Alarms in Pediatric Nocturnal Seizure Monitoring

Annals of Clinical and Translational Neurology, EarlyView.
The early‐morning surge in false seizure alarms supports exploring time‐ or state‐dependent detection thresholds to reduce false detections. ABSTRACT Seizure detection devices can improve the safety of children with epilepsy, yet high false alarms limit their clinical applicability.
Mohammad Shahbakhti, Anemoon T. Bosch, Job van der Palen, Franciscus S. Leijten, Johannes P. van Dijk, Richard H. C. Lazeron, Roland D. Thijs   +6 more
wiley   +1 more source

The ″aging″trend of the HIV/AIDS epidemic: Epidemiological characteristics and prevention and control strategies in the Binhu District of Wuxi City from 2005 to 2024

Pifu-xingbing zhenliaoxue zazhi
Objective To analyze the“aging”trend and epidemiological characteristics of HIV/AIDS prevalence in the Binhu District of Wuxi City from 2005 to 2024 and to provide evidence for optimizing prevention and control strategies for the elderly population ...
GAO Xiaoxiang, ZHOU Junyan, XIAO Lifan, DING Weiwei   +3 more
doaj   +1 more source

microRNA‐7‐5p and α‐Synuclein SAA Predict Parkinson's Disease Phenoconversion

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Corroborate blood neuron‐derived extracellular vesicle (NDEV) alpha‐synuclein (αSyn), the CSF αSyn seed amplification assay (αSyn‐SAA), and blood microRNA‐7‐5p (miR‐7‐5p) as markers for Parkinson's disease (PD) phenoconversion and determine if combining these markers would help select subjects who would be more likely to phenoconvert.
Shayan Zadegan, Praveen Velammal, Kanmani Muthiah, Madhu Jatty, Christopher Adams   +4 more
wiley   +1 more source

Anticoagulation Treatment Response Among Phenotypic ESUS Clusters: Evidence From CASPR

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate treatment effect heterogeneity across phenotypic clusters of patients with cryptogenic embolic stroke using causal inference methods. Methods From a retrospective, multicenter cohort of patients with cryptogenic embolic stroke, we estimated the treatment effect of anticoagulation versus antiplatelet therapy in patients ...
Elena Badillo Goicoechea, Patrick Ellsworth, James E. Siegler, James R. Brorson, Christina M. Lineback, Frank G. Conyers, Deborah Kerrigan, Kelsey Eklund, Shadi Yaghi, Farid Khasiyev, Emiliya Melkumova, Collin J. Culbertson, Marissa D'Souza, Dinesh V. Jillella, Patrick Glover, Hassan Aboul‐Nour, Fadi Nahab, Mahan Shahrivari, Simona Nedelcu, David S. Liebeskind, Matthew M. Smith, Aaron Rothstein, Anna Bowman, Alicia Zha, Narendra Kala, Ahmad Abu Qdais, Sami Al Kasab, Mudassir Farooqui, Diana Rojas‐Soto, Yasmin Aziz, Franziska Herpich, Jean‐Philippe Daniel, Sean L. Thompson, Vivek Patel, Thanh N. Nguyen, Siddharth Sehgal, Wenzheng Yu, Wayneho Kam, Russel Van Coevering, Oana M. Dumitrascu, Muhammad Alvi, Balaji Krishnaiah, Setareh Salehi Omran, Guillermo Linares, Eesha Singh, Hamid Ali, Mary Penckofer, Jesse M. Thon, Shani Mannion, Dalia Chahien, Lucia Chen, Fawad Talat, Mehdi Abbasi, Richa Sharma   +53 more
wiley   +1 more source

Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT The glucagon‐like peptide‐1 (GLP‐1) receptor agonists (RAs) are a relatively new class of drugs that were initially approved by the US Food and Drug Administration to improve glycemic control in patients with type 2 diabetes mellitus and, subsequently, weight reduction in patients with obesity.
Audrey Y. Chang, Farrah J. Mateen
wiley   +1 more source